• Dr. Susana Mercado receives the Likha Award for 1st place in Outstanding Creative Research category during the 2012 National Invention Contest from DOST Usec Fortunato dela Peña, DOST-TAPI Director Edgar Garcia and IPO Director IV Ms. Carmen Peralta

  • Thirteen REPS from UPLB were recently conferred the title of "Scientist" by the DOST Scientific Career System last July 19.(Photo and article courtesy of OVCRE)

The BIOTECH Building, which was initially called the Ferdinand E. Marcos Center for Biotechnology and Applied Microbiology, is located inside the 77.7 hectare Agricultural and Life Sciences Complex at UP Los Baños
BIOTECH staff and officials celebrate the 2016 UPLB Loyalty Day in full force
BIOTECH products are cost-effective and cheaper alternatives to conventional products, making use of locally available materials which are safer to the environment
Dr. Alcantara has contributed significantly to the implementation of a proactive approach to insect resistance management for transgenic maize in the Philippines.
Dr. Aggangan has contributed significantly to researches on mycorrhizal fungi as an alternative to chemical fertilizers for reforestation species; development and commercialization of MYKOVAM.
Delegates from Edu-Connect for Life and For All (Edu- Connect Southeast Asia Association) of Kaohsiung City, Taiwan visited paid a visit to BIOTECH on August 29, 2017



Investors open to tap UPLB biotech facility

 (The Philippine Star, 


MANILA, Philippines - Investors in the manufacture of biotechnology products for agricultural use can take advantage of the improvements in the biotechnology plant of the country’s premier agriculture university to service their research needs.

During the recently-concluded business forum hosted by the Department of Science and Technology (DOST) and the Department of Trade and Industry (DTI) in Los Baños, Laguna, officials of the University of the Philippines Los Baños announced that Phase 1 of the rehabilitation of its Biotech pilot plant is nearing completion.

For years, the plant has been providing assistance to entrepreneurs producing biotechnology products on a commercial scale. Such products include enzymes like rennet, amylase and cellulase; microbial fertilizers; plant growth promoting additives, probiotics, animal vaccines, antibiotics and others.

The pilot plant translates laboratory-developed technologies into semi-commercial scale production. The pilot testing stage generates data that can be used for economic feasibility studies. Markets for the products being tested at the pre-commercial stage may also be developed.

Spent for Phase 1 of the plant rehabilitation was around P15 million from the P50 million research and development grant provided by the DOST to the university for 2012.

Phase 1 of the rehabilitation of the plant is expected to be completed by January 2013. Phase 2 of the rehabilitation, on the other hand, is expected to be completed next year.

Currently installed in the plant are new bioreactors or fermenting tanks with capacities of 30 liters, 130 liters, and 200 liters. Still to be installed are bioreactors with capacities of 100 liters and 1,000 liters.

Upon the completion of the two-phase rehabilitation program, the plant would house the five bioreactors along with improved downstream processing facilities.



National Institute of Molecular Biology and Biotechnology (BIbiotech logoTECH)

University of the Philippines Los Baños

College, Laguna 403l, Philippines

Tel. Nos. 536-1620, 536-2721, 536-2725; Fax No. (049) 536-2721

Email: biotechdo.uplb@gmail.com, biotech@uplb.edu.ph

FB logo   insta   Twitter Logo